改良早期预警评分联合药品标识对神经内科静脉用药的效果

The Effect of Improved Early Warning Score Combined With Drug Labeling on Intravenous Drug Use in Neurology

目的探究改良预警评分联合药品标识管理在神经内科静脉用药管理工作中的应用效果。方法将2018年9月—2019年3月在神经内科静脉用药患者360例纳入对照组,将2019年9月—2020年3月用药患者360例纳入观察组。对照组采用常规静脉用药管理,观察组采用改良预警评分联合药品标识管理,比较两组用药安全差异。结果干预后,两组药品发放、药物配置各维度评分均较干预前提高,且观察组均高于对照组(P <0.05);观察组静脉不合理用药发生率为1.11%,低于对照组的6.11%(P <0.05)。结论将改良预警评分联合药品标识管理可提高神经内科静脉用药安全管理质量,降低静脉不合理用药发生率。

Objective To study the application value of improved early warning scoring system combined with drug labeling management on intravenous drug use in neurology department.Methods Take the medication situation of neurology department from September 2018 to February 2019 as the control group,and take the situation from September 2019 to February 2020 as the observation group,360 cases in each.The control group was administrated by routine intravenous medication,and the observation group was administrated by improved early warning score and drug labeling.The difference of drug safety between the two groups was compared.Results After intervention,the scores of drug distribution and drug allocation in the two groups were higher than those before intervention,and the incidence of unreasonable use of intravenous drugs in the observation group was 1.11%,lower than 6.11%in the control group(P<0.05).Conclusion The combination of improved early warning score and drug labeling management can improve the quality of safety management of intravenous drug use in neurology department and reduce the incidence of unreasonable intravenous drug use.